TY - JOUR
T1 - FDA officials argue over safety of new arthritis drug.
AU - Moynihan, Ray
PY - 2003/3/15
Y1 - 2003/3/15
N2 - An external advisory panel to the US Food and Drug Administration last week rejected calls from FDA safety experts to withdraw a drug for rheumatoid arthritis from the market.
AB - An external advisory panel to the US Food and Drug Administration last week rejected calls from FDA safety experts to withdraw a drug for rheumatoid arthritis from the market.
UR - http://www.scopus.com/inward/record.url?scp=0037445259&partnerID=8YFLogxK
U2 - 10.1136/bmj.326.7389.565/a
DO - 10.1136/bmj.326.7389.565/a
M3 - Article
C2 - 12637379
AN - SCOPUS:0037445259
SN - 0959-535X
VL - 326
SP - 565
EP - 565
JO - BMJ (Clinical research ed.)
JF - BMJ (Clinical research ed.)
IS - 7389
ER -